Latest Updates on NVS
-
ETFs Why Your Next Big Profit Opportunity Is Companies Getting Smaller
Joseph Papa, the CEO of Bausch Health Cos. Inc., was hired in 2016 to help turn the pharmaceutical company around. Instead, he is breaking it up. But he's not crazy. He's caught on to the fact that bigger … Read more » -
Biotechnology Read This Before You Play a Single One of the Biotechs Fighting COVID-19
Georgia, South Carolina, and Florida have announced that they are loosening quarantine restrictions; at least 13 more states have announced plans or "roadmaps" to do more or less the same thing. There's an urgent desire … Read more » -
GlaxoSmithKline Is Now a Top Pharmaceutical Stock to Buy
GlaxoSmithKline doesn't appear to be a top pharmaceutical stock to buy - at least not at first glance. Its shares have underperformed the global pharma sector by 60% over the past decade. But since Glaxo got a new CEO in 2017, the … Read more » -
Dow Jones Dow Jones Today Opens Higher as Trade War Fears Continue to Rock Wall Street
The Dow Jones today traded nearly 150-points higher in pre-market trading as investors paired losses from Friday's dramatic selloff. Read more » -
Biotechnology A "Historic" FDA Decision Could Mean Historic Gains... If You Move Now
Last week's headlines were hectic, depressing, and downright scary... ...which is why I'm thrilled to have something great to share with you today. And that is? An almost completely overlooked development in the … Read more »
